Malaysia will stop using China's Sinovac COVID-19 vaccine, the health minister said without specifying why.
Earlier, Thailand and Indonesia announced that many of their citizens would get a non-Sinovac booster jab if they had received the Chinese shot.
Malaysia's vaccine supply currently consists of jabs from Pfizer, AstraZeneca, and Sinovac. Single-dose vaccines, China's Cansino and the American Johnson & Johnson, were recently approved for use by the country's drug administration.
Under a renegotiated deal with Pfizer, Malaysia will receive 25 million doses between July and September.
Read the original story here.
Sign in or become a tippinsights member to join the conversation.
Just enter your email below to get a log in link.